BAVUNALIMAB

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 14:51:02 GMT 2023` Edited by `admin` on `Sat Dec 16 14:51:02 GMT 2023`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	3PT70X17VS
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BAVUNALIMAB

Official Name

English

IMMUNOGLOBULIN, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB22841 SINGLE-CHAIN VARIABLE FRAGMENT VH-LINKER-VL) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), (257

Common Name

English

ANTI-CTLA-4/LAG-3 BISPECIFIC ANTIBODY XMAB22841

Common Name

English

XMAB-22841

Code

English

XMAB22841

Code

English

bavunalimab [INN]

Common Name

English

PAVUNALIMAB

Common Name

English

BAVUNALIMAB [USAN]

Common Name

English

IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS LAG3 (LYMPHOCYTE ACTIVATING 3, LYMPHOCYTE-ACTIVATION 3, CD223)) AND ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)), MONOCLONAL ANTIBODY, BISPECIFIC; GAMMA1

Common Name

English

Code System Code Type Description

INN

11465